SCHEMBL30096055

SCHEMBL30096055

CCOC(=O)C(=CNC(=O)NC[C@@H](NC(=O)OC(C)(C)C)C(C)C)C(C)=O

nearest known ligand 0.44

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.44
CA2 P00918 2/20 0.44
CA7 P43166 2/20 0.44
GLO1 Q04760 1/20 0.38
CTSL P07711 1/20 0.37
CA4 P22748 1/20 0.36
CA9 Q16790 1/20 0.36
CTSK P43235 5/20 0.36
CYP1A2 P05177 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
HTT P42858 1/20 0.35
CTSS P25774 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.33
CYP2D6 P10635 1/20 0.33
ABCB1 P08183 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30096086 0.87 CA1 (0.39) CA1CA2CA7CTSLCA4
SCHEMBL30783132 0.83 CA1 (0.46) CA1CA2CA7CTSLCA4
SCHEMBL30783133 0.76 CA1 (0.40) CA1CA2CA7CTSLCA4
SCHEMBL24170368 0.71 CYP2D6 (0.49) GLO1CYP1A2CYP2C19SMN1; SMN2CYP2D6
SCHEMBL31402184 0.69 CA1 (0.59) CA1CA2CA7CA4CA9
SCHEMBL20877749 0.69 CA1 (0.59) CA1CA2CA7CA4CA9
SCHEMBL26239946 0.68 CA1 (0.67) CA1CA2CA7CTSLCA4
SCHEMBL20942487 0.68 CYP2D6 (0.41) GLO1CTSKCYP1A2CYP2C9CYP2C19
SCHEMBL30096059 0.68 GLO1 (0.50) GLO1SMN1; SMN2CYP2D6
SCHEMBL38665117 0.67 CA1 (0.71) CA1CA2CA7CTSLCA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240317692-A1 METHOD FOR PRODUCING URACIL COMPOUND NIPPON SODA CO., LTD. (JP) 2024-09-26 US disclosed
EP-4371978-A1 METHOD FOR PRODUCING URACIL COMPOUND Nippon Soda Co., Ltd. (JP) 2024-05-22 EP disclosed
WO-2023286719-A1 METHOD FOR PRODUCING URACIL COMPOUND 日本曹達株式会社 2023-01-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240317692-A1 METHOD FOR PRODUCING URACIL COMPOUND UMPS, NUDT1, DPYD CA1 1451/4885CA2 1951/4885CA7 1316/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.